Mechanism of gene expression by the glucocorticoid receptor: Role of protein-protein interactions

BioEssays

Volumn 19, Issue 2, 1997, Pages 153-160

  McEwan, Iain J ^a,b   Wright, Anthony P H ^a   Gustafsson, Jan Åke ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031081426     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950190210     Document Type: Review

References (70)

1. Dalman, F. C., Scherrer, L. C., Taylor, L. P., Akil, H. and Pratt, W. B. (1991). Localisation of the 90-kDa heat shock protein-bindig site within the hormone-binding domain of the glucocorticoid receptor by peptide competition. J. Biol. Chem. 266, 3482-3490.
2. Zilliacus, J., Wright, A. P., Carlstedt-Duke, J. and Gustafsson, J.-Å. (1995). Structural determinants of DNA-binding specificity by steroid receptors. Mol. Endocrinol. 9, 389-400.
3. Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. and Moras, D. (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375, 377-382.
4. Renaud, J. P. et al. (1995). Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378, 681-689.
5. Wagner, R. L. et al. (1995). A structural role for hormone in the thyroid hormone receptor. Nature 378, 690-697.
6. Danielsen, M., Northrop, J. P. and Ringold, G. M. (1986). The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins. EMBO J. 5, 2513-2522.
7. Giguere, V., Hollenberg, S. M., Rosenfeld, M. G. and Evans, R. M. (1986). Functional domains of the human glucocorticoid receptor. Cell 46, 645-52.
8. Godowski, P. J., Picard, D. and Yamamoto, K. R. (1988). Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins. Science 241, 812-6.
9. Hollenberg, S. M. and Evans, R. M. (1988). Multiple and cooperative transactivation domains of the human glucocorticoid receptor. Cell 55, 899-906.
10. Dahlman-Wright, K. et al. (1994). Delineation of a small region within the major transactivation domain of the human glucocorticoid receptor that mediates transactivation of gene expression. Proc. Natl Acad. Sci. USA 91, 1619-1623.
11. Ptashne, M. and Gann, A. A. F. (1990). Activators and targets. Nature 346, 329-331.
12. Danielian, P. S., White, R., Lees, J. A. and Parker, M. G. (1992). Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 11, 1025-1033.
13. Dahlman-Wright, K. et al. (1995). Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc. Natl Acad. Sci. USA 92, 1699-1703.
14. McEwan, I. J., Dahlman-Wright, K., Ford, J. and Wright, A. P. H. (1996). Functional interaction of the c-Myc transactivation domain with the TATA binding protein: evidence for an induced fit model of transactivation domain folding. Biochemistry 35, 9584-9593.
15. Dahlman-Wright, K. and McEwan, I. J. (1996). Structural studies of mutant glucorticoid receptor transactivation domains establish a link between transactivation activity in vivo and α-helix forming potential in vitro. Biochemistry 35, 1323-1327.
16. Shen, F., Triezenberg, S. J., Hensley, P., Porter, D. and Knutson, J. R. (1996). Transcriptional activation domain of the herpesvirus protein VP16 becomes conformationally constrained upon interaction with basal transcription factors. J. Biol. Chem. 271, 4827-37.
17. Stargell, L. A. and Struhl, K. (1996). Mechanisms of transcriptional activation in vivo: two steps forward. Trends Genet. 12, 311-315.
18. McEwan, I. J. et al. (1995). Mechanisms of transcriptional activation by nuclear receptors: studies on the human glucocorticoid receptor τ1 transactivation domain. Mut. Res. 333, 15-22.
19. Ing, N. H., Beekman, J. M., Tsai, S. Y., Tsai, M. J. and O'Malley, B. W. (1992). Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II). J. Biol. Chem. 267, 17617-17623.
20. Baniahmad, A., Ha, I., Reinberg, D., Tsai, S., Tsai, M. J. and O'Malley, B. W. (1993). Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. Proc. Natl Acad. Sci. USA 90, 8832-6.
21. Blanco, J. C. et al. (1995). Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl Acad. Sci. USA 92, 1535-9.
22. Cavailles, V. et al. (1995). Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 14, 3741-3751.
23. Hadzic, E. et al. (1995). A 10-amino-acid sequence in the N-terminal a/b domain of thyroid hormone receptor alpha is essential for transcriptional activation and interaction with the general transcription factor TFIIB. Mol. Cell. Biol. 15, 4507-4517.
24. Malik, S. and Karathanasis, S. (1995). Transcriptional activation by the orphan nuclear receptor ARP-1. Nucl. Acids Res. 23, 1536-1543.
25. Sadovsky, Y. et al. (1995). Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol. Cell. Biol. 15, 1554-1563.
26. Schulman, I. G., Chakravarti, D., Juguilon, H., Romo, A. and Evans, R. M. (1995). Interactions between the retinoid x receptor and a conserved region of the tata-binding protein mediate hormone-dependent transactivation. Proc. Natl Acad. Sci. USA 92, 8288-8292.
27. Fondell, J. D., Brunel, F., Hisatake, K. and Roeder, R. G. (1996). Unliganded thyroid hormone receptor alpha can target tata-binding protein for transcriptional repression. Mol. Cell. Biol. 16, 281-287.
28. Malik, S. and Karathanasis, S. K. (1996). TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4. Mol. Cell. Biol. 16, 1824-1831.
29. Eggert, M. et al. (1995). A fraction enriched in a novel glucocorticoid receptor-interacting protein stimulates receptor-dependent transcription in vitro. J. Biol. Chem. 270, 30755-30759.
30. Pfahl, M. (1993). Nuclear receptor/AP-1 interaction. Endocrinol. Rev. 14, 651-658.
31. Cato, A. C. B. and Wade, E. (1996). Molecular mechanisms of anti-inflammatory action of glucocorticoids. BioEssays 18, 371-378.
32. Heck, S. et al. (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J. 13, 4087-4095.
33. Pearce, D. and Yamamoto, K. R. (1993). Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259, 1161-1165.
34. Ray, A. and Prefontaine, K. E. (1994). Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl Acad. Sci. USA 91, 752-756.
35. Caldenhoven, E. et al. (1995). Negative cross-talk between ReIA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9, 401-412.
36. Scheinman, R. I. et al. (1995). Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943-953.
37. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A. and Karin, M. (1995). Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-90.
38. Scheinman, R. I., Cogswell, P. C., Lofquist, A. K. and Baldwin, A., Jr. (1995). Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
39. Zeiner, M. and Gehring, U. (1995). A protein that interacts with members of the nuclear hormone receptor family - identification and cDNA cloning. Proc. Natl Acad. Sci. USA 92, 11465-11469.
40. Hong, H., Kohli, K., Trivedi, A., Johnson, D. L. and Stallcup, M. R. (1996). GRIP1, a novel mouse protein that serves as a transcriptional coactivator for the hormone binding domains of steroid receptors. Proc. Natl Acad. Sci. USA 93, 4948-4952.
41. Kamei, Y. et al. (1996). A CBP integrator complex mediates trasncriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403-414.
42. Onate, S. A., Tsai, S. Y., Tsai, M.-J. and O'Malley, B. W. (1995). Sequence and characterisation of a coactivator for the steroid hormone receptor superfamily. Science 270, 1354-1357.
43. Voegal, J. J., Heine, M. J. S., Zechal, C., Chambon, P. and Gronemeyer, H. (1996). TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J. 15, 3667-3675.
44. Reik, A., Schutz, G. and Stewart, A. F. (1991). Glucocorticoids are required for establishment and maintenance of an alteration in chromatin structure: induction leads to a reversible disruption of nucleosomes over an enhancer. EMBO J. 10, 2569-2576.
45. Richard-Foy, H. and Hager, G. L. (1987) Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J. 6, 2321-2328.
46. Perlmann, T. and Wrange, Ö. (1988). Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J. 7, 3073-3079.
47. Chavez, S., Candau, R., Truss, M. and Beato, M. (1995). Constitutive repression and nuclear factor 1-dependent hormone activation of the mouse mammary tumor virus promoter in saccharomyces cerevisiae. Mol. Cell. Biol. 15, 6987-6998.
48. Peterson, C. L. and Tamkun, J. W. (1995). The SWI-SNF complex: a chromatin remodeling machine? Trends Biochem. Sci. 20, 143-146.
49. Yoshinaga, S. K., Peterson, C. L., Herskowitz, I. and Yamamoto, K. R. (1992). Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258, 1598-1604.
50. Carins, B. R., Levinson, R. S., Yamamoto, K. R. and Kornberg, R. D. (1996). Essential role of Swp73p in the fuction of yeast Swi/Snf complex. Genes Dev. 10, 2131-2144.
51. Wilson, C. J. et al. (1996). RNA polymerase II holoenzyme contains swi/snf regulators involved in chromatin remodeling. Cell 84, 235-244.
52. Brownell, J. E. et al. (1996). Tetrahymena histone acetyltransferase A a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84, 843-851.
53. Lee, J. W., Ryan, F., Swaffield, J. C., Johnston, S. A. and Moore, D. D. (1995). Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374, 91-94.
54. vom Baur, E. et al. (1996). Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1. EMBO J. 15, 110-124.
55. Jacq, X., Brou, C., Lutz, Y., Davidson, I., Chambon, P. and Tora, L. (1994). Human TAF(II)30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor. Cell 79, 107-117.
56. LeDouarin, B. et al. (1995). The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14, 2020-2033.
57. Cavailles, V., Dauvois, S., Danielian, P. S. and Parker, M. G. (1994). Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91, 10009-10013.
58. Halachmi, S. et al. (1994). Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264, 1455-1458.
59. Kurokawa, R. et al. (1995). Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377, 451-454.
60. Yen, S. and Chang, C. (1996). Cloning and characterisation of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc. Natl Acad. Sci. USA 93, 5517-5521.
61. Li, F.-Q., Ueda, H. and Hirose, S. (1994). Mediators of activation of fushi tarazu gene transcription by BmFTZ-F1. Mol. Cell. Biol. 14, 3013-3021.
62. L'Horset, F., Dauvois, S., Heery, D. M., Cavailles, V. and Parker, M. (1996). RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol. Cell. Biol. 16, 6029-6036.
63. McInerney, E. M., Tsai, M.-J., O'Malley, B. W. and Katzenellenbogen, B. S. (1996). Analysis of estrogen receptor transcriptional enhancment by a nuclear hormone receptor coactivator. Proc. Natl Acad. Sci. USA 93, 10069-10073.
64. Fondell, J. D., Ge, H. and Roeder, R. G. (1996). Ligand induction of a transcriptionally active thyroid hormone receptor complex. Proc. Natl Acad. Sci. USA 93, 8329-8333.
65. May, M., Mengus, G., Lavigne, A.-C., Chambon, P. and Davidson, I. (1996). Human TAFII28 promotes transcriptional stimulation by activating function 2 of the retinoid X receptor. EMBO J. 15, 3093-3104.
66. Schule, R., Muller, M., Kaltschmidt, C. and Renkawitz, R. (1988). Many transcription factors interact synergistically with steroid receptors. Science 242, 1418-1420.
67. Strahle, U., Schmid, W. and Schutz, G. (1988). Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J. 7, 3389-3395.
68. Lee, J. W., Choi, H. S., Gyuris, J., Brent, R. and Moore, D. D. (1995). Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor. Mol. Endocrinol. 9, 243-254.
69. Schwerk, C., Klotzbucher, M., Sachs, M., Ulber, V. and Klein-Hitpass, L. (1995). Identification of a transactivation function in the progesterone receptor that interacts with the TAFII110 subunit of the TFIID complex. J. Biol. Chem. 270, 21331-21338.
70. Schmitt, J. and Stunnenberg, H. G. (1993). The glucocorticoid receptor hormone binding domain mediates transcriptional activation in vitro in the absence of ligand. Nucl. Acids Res. 21, 2673-2681.